{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:01:07Z","timestamp":1790892067079,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["DFD-170763"],"award-info":[{"award-number":["DFD-170763"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24AG081325"],"award-info":[{"award-number":["K24AG081325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG066519"],"award-info":[{"award-number":["P30AG066519"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG064228"],"award-info":[{"award-number":["R01AG064228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Higher order regulation of autonomic function is maintained by the coordinated activity of specific cortical and subcortical brain regions, collectively referred to as the central autonomic network (CAN). Autonomic changes are frequently observed in Alzheimer\u2019s disease (AD)\u00a0and dementia, but no studies to date have investigated whether plasma AD biomarkers are associated with CAN functional connectivity changes in at risk older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Independently living older adults (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009122) without major neurological or psychiatric disorder were recruited from the community. Participants underwent resting-state brain fMRI and a CAN network derived from a voxel-based meta-analysis was applied for overall, sympathetic, and parasympathetic CAN connectivity using the CONN Functional Toolbox. Sensorimotor network connectivity was studied as a negative control. Plasma levels of amyloid (A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      ), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were assessed using digital immunoassay. The relationship between plasma AD biomarkers and within-network functional connectivity was studied using multiple linear regression adjusted for demographic covariates and Apolipoprotein E (\n                      <jats:italic>APOE<\/jats:italic>\n                      ) genotype. Interactive effects with\n                      <jats:italic>APOE4<\/jats:italic>\n                      carrier status were also assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All autonomic networks were positively associated with A\u03b2\n                      <jats:sub>42\/40<\/jats:sub>\n                      ratio and remained so after adjustment for age, sex, and\n                      <jats:italic>APOE4<\/jats:italic>\n                      carrier status. Overall and parasympathetic networks were negatively associated with GFAP. The relationship between the parasympathetic CAN and GFAP was moderated by\n                      <jats:italic>APOE<\/jats:italic>\n                      4 carrier status, wherein\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers with low parasympathetic CAN connectivity displayed the highest plasma GFAP concentrations (\n                      <jats:italic>B<\/jats:italic>\n                      \u2009=\u2009910.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.004). Sensorimotor connectivity was not associated with any plasma AD biomarkers, as expected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The present study findings suggest that CAN function is associated with plasma AD biomarker levels. Specifically, lower CAN functional connectivity is associated with decreased plasma A\u03b2\n                      <jats:sub>42\/40<\/jats:sub>\n                      , indicative of cerebral amyloidosis, and increased plasma GFAP in\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers at risk for AD. These findings could suggest higher order autonomic and parasympathetic dysfunction in very early-stage AD, which may have clinical implications.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-024-01486-9","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T01:02:02Z","timestamp":1717808522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Central autonomic network dysfunction and plasma Alzheimer\u2019s disease biomarkers in older adults"],"prefix":"10.1186","volume":"16","author":[{"given":"Trevor","family":"Lohman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Engstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemah","family":"Shenasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Paul M.","family":"Alitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Gaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Duke","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Sordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian F.","family":"Thayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"key":"1486_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0025-6196(12)62272-1","volume":"68","author":"EE Benarroch","year":"1993","unstructured":"Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993;68:988\u20131001.","journal-title":"Mayo Clin Proc"},{"key":"1486_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511541667","volume-title":"Integrative action of the autonomic nervous system: Neurobiology of Homeostasis","author":"W J\u00e4nig","year":"2006","unstructured":"J\u00e4nig W. Integrative action of the autonomic nervous system: neurobiology of homeostasis. Cambridge: Cambridge University Press; 2006."},{"key":"1486_CR3","doi-asserted-by":"publisher","first-page":"10503","DOI":"10.1523\/JNEUROSCI.1103-13.2013","volume":"33","author":"F Beissner","year":"2013","unstructured":"Beissner F, Meissner K, B\u00e4r KJ, Napadow V. The autonomic brain: an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci. 2013;33:10503\u201311.","journal-title":"J Neurosci"},{"key":"1486_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/S1980-57642009DN20300004","volume":"2","author":"E Engelhardt","year":"2008","unstructured":"Engelhardt E, Laks J. Alzheimer disease neuropathology: understanding autonomic dysfunction. Dement Neuropsychol. 2008;2:183\u201391.","journal-title":"Dement Neuropsychol"},{"key":"1486_CR5","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.neurobiolaging.2011.11.017","volume":"33","author":"O Collins","year":"2012","unstructured":"Collins O, Dillon S, Finucane C, Lawlor B, Kenny RA. Parasympathetic autonomic dysfunction is common in mild cognitive impairment. Neurobiol Aging. 2012;33:2324\u201333.","journal-title":"Neurobiol Aging"},{"key":"1486_CR6","doi-asserted-by":"crossref","unstructured":"Tulb\u0103 D, Cozma L, Popescu BO, Davidescu EI. Dysautonomia in Alzheimer\u2019s disease. Med (Kaunas). 2020;56.","DOI":"10.3390\/medicina56070337"},{"key":"1486_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JAD-150169","volume":"47","author":"C Jensen-Dahm","year":"2015","unstructured":"Jensen-Dahm C, et al. Autonomic dysfunction in patients with mild to moderate Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47:681\u20139.","journal-title":"J Alzheimers Dis"},{"key":"1486_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.mehy.2005.10.036","volume":"67","author":"DR Royall","year":"2006","unstructured":"Royall DR, Gao JH, Kellogg DL Jr. Insular Alzheimer\u2019s disease pathology as a cause of age-related autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses. 2006;67:747\u201358.","journal-title":"Med Hypotheses"},{"key":"1486_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuroimage.2019.04.075","volume":"197","author":"G Valenza","year":"2019","unstructured":"Valenza G, et al. The central autonomic network at rest: uncovering functional MRI correlates of time-varying autonomic outflow. NeuroImage. 2019;197:383\u201390.","journal-title":"NeuroImage"},{"key":"1486_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00429-020-02075-w","volume":"225","author":"K Ding","year":"2020","unstructured":"Ding K, et al. Central autonomic network functional connectivity: correlation with baroreflex function and cardiovascular variability in older adults. Brain Struct Funct. 2020;225:1575\u201385.","journal-title":"Brain Struct Funct"},{"key":"1486_CR11","doi-asserted-by":"crossref","unstructured":"Nair SS et al. Investigation of autonomic dysfunction in Alzheimer\u2019s disease-a computational model-based approach. Brain Sci. 2023;13.","DOI":"10.3390\/brainsci13091322"},{"key":"1486_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ggi.12679","volume":"17","author":"Z Nonogaki","year":"2017","unstructured":"Nonogaki Z, Umegaki H, Makino T, Suzuki Y, Kuzuya M. Relationship between cardiac autonomic function and cognitive function in Alzheimer\u2019s disease. Geriatr Gerontol Int. 2017;17:92\u20138.","journal-title":"Geriatr Gerontol Int"},{"key":"1486_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/brain.2014.0236","volume":"4","author":"MR Brier","year":"2014","unstructured":"Brier MR, Thomas JB, Ances BM. Network dysfunction in Alzheimer\u2019s disease: refining the disconnection hypothesis. Brain Connect. 2014;4:299\u2013311.","journal-title":"Brain Connect"},{"key":"1486_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","volume":"67","author":"YI Sheline","year":"2010","unstructured":"Sheline YI, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry. 2010;67:584\u20137.","journal-title":"Biol Psychiatry"},{"key":"1486_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/JAD-2011-102154","volume":"25","author":"S Neufang","year":"2011","unstructured":"Neufang S, et al. Disconnection of frontal and parietal areas contributes to impaired attention in very early Alzheimer\u2019s disease. J Alzheimers Dis. 2011;25:309\u201321.","journal-title":"J Alzheimers Dis"},{"key":"1486_CR16","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1001\/archneur.64.10.1482","volume":"64","author":"G Allen","year":"2007","unstructured":"Allen G, et al. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol. 2007;64:1482\u20137.","journal-title":"Arch Neurol"},{"key":"1486_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.neuroimage.2005.12.033","volume":"31","author":"L Wang","year":"2006","unstructured":"Wang L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer\u2019s disease: evidence from resting state fMRI. NeuroImage. 2006;31:496\u2013504.","journal-title":"NeuroImage"},{"key":"1486_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ana.26168","volume":"90","author":"S Dautricourt","year":"2021","unstructured":"Dautricourt S, et al. Longitudinal changes in hippocampal network connectivity in Alzheimer\u2019s disease. Ann Neurol. 2021;90:391\u2013406.","journal-title":"Ann Neurol"},{"key":"1486_CR19","doi-asserted-by":"crossref","unstructured":"Johnson-Greene D, Dementia Rating Scale-2 (DRS-2) By, Jurica PJ, Leitten CL. and S. Mattis: psychological assessment resources, 2001. Arch Clin Neuropsychol. 2004;19:145\u2013147.","DOI":"10.1016\/j.acn.2003.07.003"},{"key":"1486_CR20","doi-asserted-by":"crossref","unstructured":"Kapoor A et al. Increased levels of circulating angiogenic cells and signaling proteins in older adults with cerebral small vessel disease. Front Aging Neurosci. 2021;13.","DOI":"10.3389\/fnagi.2021.711784"},{"key":"1486_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/brain.2012.0073","volume":"2","author":"S Whitfield-Gabrieli","year":"2012","unstructured":"Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125\u201341.","journal-title":"Brain Connect"},{"key":"1486_CR22","doi-asserted-by":"crossref","unstructured":"Nieto-Castanon A. Handbook of functional connectivity magnetic resonance imaging methods in CONN. 2020.","DOI":"10.56441\/hilbertpress.2207.6598"},{"key":"1486_CR23","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1212\/WNL.0000000000012513","volume":"97","author":"MJ Grothe","year":"2021","unstructured":"Grothe MJ, et al. Associations of fully automated CSF and novel plasma biomarkers with Alzheimer disease neuropathology at autopsy. Neurology. 2021;97:e1229\u201342.","journal-title":"Neurology"},{"key":"1486_CR24","unstructured":"Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford Press, New York, NY, US. 2013, pp. xvii, 507-xvii, 507."},{"key":"1486_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13059-019-1716-1","volume":"20","author":"K Korthauer","year":"2019","unstructured":"Korthauer K, et al. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 2019;20:118.","journal-title":"Genome Biol"},{"key":"1486_CR26","doi-asserted-by":"publisher","first-page":"e62101","DOI":"10.1371\/journal.pone.0062101","volume":"8","author":"CA Mayer","year":"2013","unstructured":"Mayer CA, et al. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE. 2013;8:e62101.","journal-title":"PLoS ONE"},{"key":"1486_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Reviews Neurol. 2022;18:158\u201372.","journal-title":"Nat Reviews Neurol"},{"key":"1486_CR28","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.2147\/JIR.S342097","volume":"14","author":"L Amalia","year":"2021","unstructured":"Amalia L. Glial fibrillary acidic protein (GFAP): Neuroinflammation Biomarker in Acute ischemic stroke. J Inflamm Res. 2021;14:7501\u20136.","journal-title":"J Inflamm Res"},{"key":"1486_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 2021;78:1471\u201383.","journal-title":"JAMA Neurol"},{"key":"1486_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091309","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang K-A. GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12091309.","journal-title":"Cells"},{"key":"1486_CR31","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1002\/alz.12879","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer\u2019s disease: associations with A\u03b2-PET, neurodegeneration, and cognition. Alzheimer\u2019s Dement. 2023;19:2790\u2013804.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1486_CR32","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain. 2021;144:3505\u201316.","journal-title":"Brain"},{"key":"1486_CR33","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","volume":"269","author":"G Giacomucci","year":"2022","unstructured":"Giacomucci G, et al. Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment. J Neurol. 2022;269:4270\u201380.","journal-title":"J Neurol"},{"key":"1486_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","volume":"10","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P, et al. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10:71.","journal-title":"Alzheimers Res Ther"},{"key":"1486_CR35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/HYPERTENSIONAHA.119.13664","volume":"74","author":"RAA de Heus","year":"2019","unstructured":"de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen J. Blood pressure variability and progression of clinical Alzheimer disease. Hypertension. 2019;74:1172\u201380.","journal-title":"Hypertension"},{"key":"1486_CR36","doi-asserted-by":"publisher","first-page":"104907","DOI":"10.1016\/j.neubiorev.2022.104907","volume":"143","author":"MN Jarczok","year":"2022","unstructured":"Jarczok MN, et al. Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations. Neurosci Biobehav Rev. 2022;143:104907.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"1486_CR37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(97)11144-8","volume":"351","author":"MTL Rovere","year":"1998","unstructured":"Rovere MTL, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478\u201384.","journal-title":"Lancet"},{"key":"1486_CR38","doi-asserted-by":"publisher","first-page":"H680","DOI":"10.1152\/ajpheart.1987.253.3.H680","volume":"253","author":"RW deBoer","year":"1987","unstructured":"deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol Heart Circ Physiol. 1987;253:H680\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1486_CR39","doi-asserted-by":"publisher","first-page":"R815","DOI":"10.1152\/ajpregu.00051.2002","volume":"283","author":"PA Lanfranchi","year":"2002","unstructured":"Lanfranchi PA, Somers VK. Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol. 2002;283:R815\u2013826.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1486_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JAD-210435","volume":"83","author":"IJ Sible","year":"2021","unstructured":"Sible IJ, Bangen KJ, Blanken AE, Ho JK, Nation DA. Antemortem visit-to-visit blood pressure variability predicts cerebrovascular lesion burden in autopsy-confirmed Alzheimer\u2019s disease. J Alzheimers Dis. 2021;83:65\u201375.","journal-title":"J Alzheimers Dis"},{"key":"1486_CR41","doi-asserted-by":"publisher","first-page":"e2446","DOI":"10.1212\/WNL.0000000000200302","volume":"98","author":"IJ Sible","year":"2022","unstructured":"Sible IJ, Nation DA. I. on behalf of Alzheimer\u2019s Disease Neuroimaging, visit-to-visit blood pressure variability and CSF Alzheimer disease biomarkers in cognitively unimpaired and mildly impaired older adults. Neurology. 2022;98:e2446\u201353.","journal-title":"Neurology"},{"key":"1486_CR42","doi-asserted-by":"crossref","unstructured":"Lohman T et al. Blood pressure variability, central autonomic network dysfunction and cerebral small vessel disease in APOE4 carriers. medRxiv. 2023.","DOI":"10.1101\/2023.12.13.23299556"},{"key":"1486_CR43","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1038\/s41598-023-30167-0","volume":"13","author":"J Min","year":"2023","unstructured":"Min J, et al. Modulating heart rate oscillation affects plasma amyloid beta and tau levels in younger and older adults. Sci Rep. 2023;13:3967.","journal-title":"Sci Rep"},{"key":"1486_CR44","doi-asserted-by":"publisher","unstructured":"Grajski KA, Bressler SL; Alzheimer\u2019s Disease Neuroimaging Initiative. Differential medial temporal lobe and default-mode network functional connectivity and morphometric changes in Alzheimer\u2019s disease. Neuroimage Clin. 2019;23:101860. https:\/\/doi.org\/10.1016\/j.nicl.2019.101860. Epub 2019 May 18. PMID: 31158694; PMCID: PMC6545401.","DOI":"10.1016\/j.nicl.2019.101860"},{"key":"1486_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jalz.2008.04.006","volume":"4","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, et al. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer\u2019s disease and mild cognitive impairment. Alzheimers Dement. 2008;4:265\u201370.","journal-title":"Alzheimers Dement"},{"key":"1486_CR46","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.0308627101","volume":"101","author":"MD Greicius","year":"2004","unstructured":"Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA. 2004;101:4637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1486_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1486_CR48","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del K, Tredici. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70:960\u20139.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01486-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01486-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01486-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T01:03:33Z","timestamp":1717808613000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01486-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01486-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Informed consent was obtained from all participants and the study was approved by the Institutional Review Board (IRB) at the University of California, Irvine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}